Company intelligence / Profile preview

Synergy Dermatology

Princeton, New Jersey, United Statessynergyderm.com ↗

Ownership: Private
Development stage: Other

Overview

Synergy Dermatology is a clinical-stage pharmaceutical company focused on the development and commercialization of innovative topical therapies for dermatological conditions. The company's lead programs utilize advanced small molecule inhibitors, specifically targeting the Janus kinase (JAK) pathway to address inflammatory skin diseases. Synergy Dermatology aims to provide safer and more effective alternatives to systemic treatments for indications such as atopic dermatitis and psoriasis. By leveraging specialized formulation technologies, the company seeks to optimize drug delivery and patient outcomes in the specialty dermatology market.

Therapeutic areas: Dermatology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Synergy Dermatology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synergy Dermatology.

Explore the full profile